
SunOpta, Inc. (NASDAQ:STKL - Free Report) TSE: SOY - William Blair lifted their FY2025 earnings per share estimates for SunOpta in a report released on Thursday, August 7th. William Blair analyst J. Andersen now expects that the company will post earnings of $0.20 per share for the year, up from their previous estimate of $0.19. The consensus estimate for SunOpta's current full-year earnings is $0.13 per share. William Blair also issued estimates for SunOpta's FY2026 earnings at $0.32 EPS.
SunOpta Trading Up 4.5%
SunOpta stock traded up $0.27 during trading on Friday, reaching $6.26. 1,151,101 shares of the company were exchanged, compared to its average volume of 974,310. SunOpta has a 52-week low of $3.64 and a 52-week high of $8.11. The company has a market capitalization of $735.80 million, a P/E ratio of -104.33 and a beta of 1.32. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.96 and a quick ratio of 0.39. The stock's 50 day simple moving average is $6.04 and its two-hundred day simple moving average is $5.81.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.04 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. SunOpta had a positive return on equity of 12.82% and a negative net margin of 0.66%. The firm had revenue of $191.49 million for the quarter, compared to the consensus estimate of $185.36 million.
Insider Buying and Selling
In other SunOpta news, CEO Brian W. Kocher bought 10,000 shares of SunOpta stock in a transaction on Tuesday, June 10th. The shares were bought at an average price of $5.72 per share, for a total transaction of $57,200.00. Following the completion of the transaction, the chief executive officer directly owned 10,000 shares of the company's stock, valued at $57,200. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders own 1.90% of the company's stock.
Institutional Investors Weigh In On SunOpta
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Cooperman Leon G raised its position in SunOpta by 9.1% in the first quarter. Cooperman Leon G now owns 6,097,331 shares of the company's stock valued at $29,633,000 after purchasing an additional 507,990 shares during the period. Granahan Investment Management LLC raised its position in SunOpta by 20.3% in the first quarter. Granahan Investment Management LLC now owns 3,346,836 shares of the company's stock valued at $16,266,000 after purchasing an additional 564,621 shares during the period. Geode Capital Management LLC raised its position in SunOpta by 4.4% in the second quarter. Geode Capital Management LLC now owns 2,330,166 shares of the company's stock valued at $13,517,000 after purchasing an additional 98,077 shares during the period. Vanguard Group Inc. raised its position in SunOpta by 3.3% in the fourth quarter. Vanguard Group Inc. now owns 2,207,838 shares of the company's stock valued at $17,002,000 after purchasing an additional 71,116 shares during the period. Finally, Harbor Capital Advisors Inc. raised its position in SunOpta by 4.3% in the first quarter. Harbor Capital Advisors Inc. now owns 1,836,989 shares of the company's stock valued at $8,928,000 after purchasing an additional 75,067 shares during the period. Hedge funds and other institutional investors own 85.39% of the company's stock.
SunOpta Company Profile
(
Get Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Read More
Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.